ALK expression in triple-negative breast cancer cell line versus normal cell line. (A) Total proteins isolated from MDA-MB231 and MCF12A cells were immunoblotted with antibodies against ALK and beta-actin. (B) Relative expression of ALK was calculated using spot densitometry on total protein immunoblots of MDA-MB231 and MCF12A cells. Expression of ALK was normalized with beta-actin
Figure S8. Claudin-low T11 cells were grown in ultra-low attachment plates in mammosphere media for ...
Figure S2. The MEK inhibitor PD98059 and the PI3K inhibitor Wortmannin prevent respectively the acti...
Figure S2. ALDH1A1 activity promotes the release of angiogenic factors in MCF-7. a. Cytokine ELISA p...
Kaplan-Meier survival analysis for overall survival of ALK expression in breast cancer. Breast cance...
Details of primary antibodies used in the study. Details of primary antibodies used in the study inc...
Figure S2. Effects of VPA and SAHA treatments on PMCA4b protein expression and histone H3 acetylatio...
siRNA targeting AKAP95 does not influence PKA-induced ERαS305 phosphorylation. MCF-7 breast cancer c...
Gene expression of invasive and mesenchymal markers in cell isolates. Mammary epithelial cell (MEC),...
Effects of AKT and MAPK inhibition on apoptosis in BT474 and MDAMB361 cells. Cell lines grown in 2D ...
Figure S3. (A) Heatmap representing the top 25 upregulated and downregulated proteins in untreated c...
Figure S4. IKKε and p52 or MEK supports viability in LA conditions in at least two TNBC lines. Growt...
Figure S1. GPER stimulation triggers FAK Y397 activation in SUM159 TNBC cells. Immunoblots showing F...
Figure S1. Effects of VPA and SAHA treatments on Ca2+ pump expressions in different breast cancer ce...
Figure S7. TCGA RPPA data was mined to compare the expression of GSK3β in TNBCs and other types of b...
NPM-ALK/STAT3 is not differentially activated or expressed between RU and RR cells. (a) The protein ...
Figure S8. Claudin-low T11 cells were grown in ultra-low attachment plates in mammosphere media for ...
Figure S2. The MEK inhibitor PD98059 and the PI3K inhibitor Wortmannin prevent respectively the acti...
Figure S2. ALDH1A1 activity promotes the release of angiogenic factors in MCF-7. a. Cytokine ELISA p...
Kaplan-Meier survival analysis for overall survival of ALK expression in breast cancer. Breast cance...
Details of primary antibodies used in the study. Details of primary antibodies used in the study inc...
Figure S2. Effects of VPA and SAHA treatments on PMCA4b protein expression and histone H3 acetylatio...
siRNA targeting AKAP95 does not influence PKA-induced ERαS305 phosphorylation. MCF-7 breast cancer c...
Gene expression of invasive and mesenchymal markers in cell isolates. Mammary epithelial cell (MEC),...
Effects of AKT and MAPK inhibition on apoptosis in BT474 and MDAMB361 cells. Cell lines grown in 2D ...
Figure S3. (A) Heatmap representing the top 25 upregulated and downregulated proteins in untreated c...
Figure S4. IKKε and p52 or MEK supports viability in LA conditions in at least two TNBC lines. Growt...
Figure S1. GPER stimulation triggers FAK Y397 activation in SUM159 TNBC cells. Immunoblots showing F...
Figure S1. Effects of VPA and SAHA treatments on Ca2+ pump expressions in different breast cancer ce...
Figure S7. TCGA RPPA data was mined to compare the expression of GSK3β in TNBCs and other types of b...
NPM-ALK/STAT3 is not differentially activated or expressed between RU and RR cells. (a) The protein ...
Figure S8. Claudin-low T11 cells were grown in ultra-low attachment plates in mammosphere media for ...
Figure S2. The MEK inhibitor PD98059 and the PI3K inhibitor Wortmannin prevent respectively the acti...
Figure S2. ALDH1A1 activity promotes the release of angiogenic factors in MCF-7. a. Cytokine ELISA p...